Merck (NYSE: MRK) details integration plans
by CS Chen Merck & Co., Inc. (NYSE: MRK), one of the largest pharmaceutical companies in the world, which is known for its treatments like Gardasil (human papilloma virus), Propecia (baldness), and Zocor (cholesterol) detailed its global structuring program on Friday. The company’s integration plans aim at its research and development, business operations, and manufacturing. … Read More »